A discussion about the effectiveness of new cancer drugs and the impact of their high price on patients and doctors.

Guests

  • Randy Burkholder Associate Vice President of Policy, Pharmaceutical Research and Manufacturers of America
  • Dr. Ed Pezalla National Medical Director for Aetna Pharmacy Management, Hartford CT.
  • Kevin LaMartina Patient Resource Navigator, The American Cancer Society, at St. Agnes Hospital, Baltimore, MD.
  • Dr. Neal Meropol Director, Gastrointestinal Cancer Program, Fox Chase Cancer Center, Philadelphia, PA
  • Dr. John Marshall Chief, Division of Hematology/Oncology at Georgetown's Lombardi Comprehensive Cancer Center, Washington, D.C.

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Catherine Price: “Vitamania”

Thursday, Feb 26 2015Tens of millions of Americans take nutritional supplements. New studies allege some pills do not contain what is on the label. Other research indicates consumers may be ingesting too many vitamins. New concerns about dietary supplements.

New Research On Preventing Peanut Allergies

Wednesday, Feb 25 2015The number of children allergic to peanuts has skyrocketed. A new study suggests doctors have been giving the wrong advice about peanuts for years. A discussion of what the latest research says about preventing the sometimes life-threatening allergy.